Report Highlights
The global high-performance liquid chromatography (HPLC) market should reach $5.7 billion by 2027 from $4.5 billion in 2022 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2022 to 2027.
Report Includes
- 36 tables
- An overview of the global market for High-Performance Liquid Chromatography (HPLC)
- Analyses of global market trends, with data from 2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for HPLC market by product type, application type, and region
- Description of HPLC types and discussion on role of HPLC in foods and beverages, pharmaceutical, and life science industries.
- Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants
- Company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA and Thermo Fisher Scientific Inc.
Report Scope
This report aims to provide a comprehensive study of the global market for high-performance liquid chromatography (HPLC). It describes the different types of products used in HPLC and their current and historical market revenues.
In this report, the high-performance liquid chromatography (HPLC) market is segmented by product type, application, and region. Based on product type, the market is segmented into instruments, consumables, and accessories. Based on application type, the market is segmented into clinical research, diagnostics, forensics, and other applications. The market is segmented by region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
However, this report does not cover high-performance liquid chromatography (HPLC) software, and ultra-performance liquid chromatography (UPLC).
For a more in-depth understanding of the market, the report includes profiles of major players and their market shares in the high-performance liquid chromatography (HPLC) market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||||
| Base year market size | $4.2 billion | ||||||||||||||||||||||||
| Market size forecast | $5.7 billion | ||||||||||||||||||||||||
| Growth rate | CAGR of 5.2% for the forecast period of 2022-2027 | ||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||
| Segments covered | product type, application type, and region | ||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (ROW) | ||||||||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Australia, Rest of Asia-Pacific, Middle East, Africa, and South America | ||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Chromatography in Pharmaceuticals and Biotechnology: Global Markets
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Chromatography: A BCC Research Outlook
The global market for chromatography reagents should grow from $10.0 billion in 2018 to $14.2 billion by 2023 at a compound annual growth rate (CAGR) of 7.4% from 2018 through 2023.
Global Markets for Reagents for Chromatography
The global market for chromatography reagents will grow from $8.3 billion in 2014 to nearly $11 billion by 2019 at a compound annual growth rate (CAGR) of 5.2% between 2014 and 2019.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More